| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
328 |
305 |
$34K |
| 99223 |
Prolong inpt eval add15 m |
181 |
174 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
363 |
336 |
$8K |
| 0002A |
|
184 |
183 |
$7K |
| 0001A |
|
193 |
190 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$5K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
59 |
58 |
$4K |
| 0071A |
|
39 |
36 |
$2K |
| 0031A |
|
19 |
17 |
$716.38 |
| 0072A |
|
17 |
17 |
$716.38 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
84 |
45 |
$596.16 |
| 0003A |
|
16 |
12 |
$565.68 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15 |
13 |
$504.42 |
| 91300 |
|
363 |
338 |
$3.33 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
49 |
47 |
$0.16 |
| 91303 |
|
19 |
17 |
$0.15 |
| 91307 |
|
33 |
30 |
$0.05 |